PILL Holdings — Direxion Daily Pharmaceutical & Medical Bull 3X Shares
All 62 reported holdings of Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Goldman Financial | 18.99% | $2.45M |
| Dreyfus Government Cash Manage | 3.75% | $483.28K |
| Organon & Company | 2.77% | $357.19K |
| Corcept Therapeutics, Inc. | 1.85% | $237.90K |
| Enliven Therapeutics, Inc. | 1.80% | $231.71K |
| Axsome Therapeutics, Inc. | 1.74% | $224.58K |
| Omeros Corp. | 1.64% | $211.16K |
| Perrigo Company PLC | 1.62% | $208.24K |
| Definium Therapeutics, Inc. | 1.57% | $202.61K |
| Nektar Therapeutics | 1.55% | $200.10K |
| Trevi Therapeutics, Inc. | 1.54% | $198.85K |
| Terns Pharmaceuticals, Inc. | 1.51% | $195.26K |
| Indivior Pharmaceuticals, Inc. | 1.50% | $193.35K |
| Pacira Biosciences, Inc. | 1.49% | $192.63K |
| Harrow, Inc. | 1.47% | $189.28K |
| Jazz Pharmaceuticals PLC | 1.47% | $189.01K |
| Harmony Biosciences Holdings, Inc. | 1.45% | $187.34K |
| Royalty Pharma PLC | 1.44% | $185.08K |
| Amylyx Pharmaceuticals, Inc. | 1.43% | $184.90K |
| Viatris, Inc. | 1.43% | $184.54K |
| Crinetics Pharmaceuticals, Inc. | 1.40% | $180.95K |
| Ani Pharmaceuticals, Inc. | 1.39% | $179.72K |
| Ligand Pharmaceuticals, Inc. | 1.39% | $178.97K |
| Mbx Biosciences, Inc. | 1.37% | $177.27K |
| Innoviva, Inc. | 1.37% | $176.91K |
| Liquidia Corp. | 1.36% | $175.43K |
| Amneal Pharmaceuticals, Inc. | 1.36% | $174.71K |
| Xeris Biopharma Holdings, Inc. | 1.35% | $174.65K |
| Bristol-Myers Squibb Company | 1.35% | $174.26K |
| Edgewise Therapeutics, Inc. | 1.34% | $172.35K |
| Ocular Therapeutix, Inc. | 1.32% | $170.18K |
| Pfizer, Inc. | 1.31% | $168.77K |
| Nuvation Bio, Inc. | 1.30% | $167.28K |
| Zoetis, Inc. | 1.28% | $165.67K |
| Elanco Animal Health, Inc. | 1.28% | $164.58K |
| Collegium Pharmaceutical, Inc. | 1.27% | $163.39K |
| Johnson & Johnson | 1.27% | $163.19K |
| Merck & Company, Inc. | 1.26% | $162.13K |
| Alumis, Inc. | 1.25% | $161.74K |
| Eli Lilly & Company | 1.25% | $160.75K |
| Tarsus Pharmaceuticals, Inc. | 1.22% | $157.05K |
| Supernus Pharmaceuticals, Inc. | 1.21% | $155.62K |
| Phibro Animal Health Corp. | 1.20% | $154.81K |
| Eyepoint, Inc. | 1.18% | $152.64K |
| Prestige Consumer Healthcare, Inc. | 1.16% | $149.92K |
| Amphastar Pharmaceuticals, Inc. | 1.13% | $146.12K |
| Theravance Biopharma, Inc. | 1.02% | $131.51K |
| Phathom Pharmaceuticals, Inc. | 1.01% | $130.58K |
| Rapport Therapeutics, Inc. | 1.01% | $130.23K |
| Esperion Therapeutics, Inc. | 1.00% | $128.29K |
| Cormedix, Inc. | 0.95% | $122.96K |
| Arvinas, Inc. | 0.81% | $104.76K |
| Bioage Labs, Inc. | 0.81% | $103.88K |
| Zevra Therapeutics, Inc. | 0.75% | $96.55K |
| Maze Therapeutics, Inc. | 0.71% | $90.93K |
| Septerna, Inc. | 0.69% | $89.34K |
| Wave Life Sciences Ltd. | 0.67% | $86.51K |
| Lb Pharmaceuticals, Inc. | 0.64% | $82.64K |
| Fulcrum Therapeutics, Inc. | 0.59% | $76.63K |
| Aquestive Therapeutics, Inc. | 0.56% | $71.93K |
| Alto Neuroscience, Inc. | 0.43% | $54.99K |
| Goldman Sachs Liq Es Fd A | 0.00% | $0 |
PILL overview: performance, fees, allocation and SEC filings